GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

BOLT · Jun 30, 2023

Bolt Biotherapeutics, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0000950170-23-039061General Corporate
Capex intensityRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

2.23% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating cash generationRAWCurrent state valid · history insufficient
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-1054.57% · OPTIONAL · NOT_ENOUGH_HISTORY

Revenue growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.fundamentals.revenue

2.87% · CORE · NOT_ENOUGH_HISTORY

Operating marginRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.operating_margin

-1383.95% · CORE · NOT_ENOUGH_HISTORY

R&D intensityRAWCurrent state valid · history insufficient
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

1091.70% · OPTIONAL · NOT_ENOUGH_HISTORY

SBC intensityRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

163.99% · OPTIONAL · NOT_ENOUGH_HISTORY

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History13 statesSelf-history eligible
Jun 30, 20230/6 normalizedLevel 3Sep 30, 20230/6 normalizedLevel 3Dec 31, 20230/6 normalizedLevel 3Mar 31, 20240/6 normalizedLevel 3Jun 30, 20245/6 normalizedLevel 3Sep 30, 20245/6 normalizedLevel 3Dec 31, 20245/6 normalizedLevel 3Mar 31, 20254/5 normalizedLevel 3Jun 30, 20255/5 normalizedLevel 3Sep 30, 20255/5 normalizedLevel 3Dec 31, 20256/6 normalizedLevel 3Mar 31, 20265/5 normalizedLevel 3Jun 30, 20265/5 normalizedLevel 4
Period transition

What moved in the state?

Capex Intensity Increased
Previous
0.16%
Current
2.23%
Delta
2.07%
Cash Generation Increased
Previous
-1281.43%
Current
-1054.57%
Delta
226.86%
Profitability Decreased
Previous
-1008.49%
Current
-1383.95%
Delta
-375.46%
R And D Intensity Increased
Previous
800.93%
Current
1091.70%
Delta
290.76%
Sbc Intensity Increased
Previous
135.60%
Current
163.99%
Delta
28.39%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Transitioned To · BOLT Fundamental State →Transitioned To · BOLT CAPEX_INTENSITY_INCREASED →Transitioned To · BOLT CASH_GENERATION_INCREASED →Transitioned To · BOLT PROFITABILITY_DECREASED →Transitioned To · BOLT R_AND_D_INTENSITY_INCREASED →Transitioned To · BOLT SBC_INTENSITY_INCREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.